Xtandi (enzalutamide) 40 mg film-coated tablets, 112 tablets — original (Astellas, Netherlands) Treatment of metastatic castration-resistant cancer Targeted cancer therapy. Delivery of medications from Europe, cash on delivery. Order by calling +380996042415, Viber, WhatsApp.
-
Indications
- The drug Xtandi is indicated for the treatment of metastatic castration-resistant prostate cancer in adult men with disease progression during or after chemotherapy including docetaxel.
- Trade Name:Kstandi
- Chemical Name:Enzalutamide
- Dosage:40
- Quantity:112
- Form of Issue:Tablets
- Manufacturer:Astellas
No reviews yet